0001246360-14-002136.txt : 20140421
0001246360-14-002136.hdr.sgml : 20140421
20140421161409
ACCESSION NUMBER: 0001246360-14-002136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140417
FILED AS OF DATE: 20140421
DATE AS OF CHANGE: 20140421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDTRONIC INC
CENTRAL INDEX KEY: 0000064670
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 410793183
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0429
BUSINESS ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
STREET 2: MS LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
BUSINESS PHONE: 7635144000
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szyman Catherine M
CENTRAL INDEX KEY: 0001438538
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-07707
FILM NUMBER: 14774019
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY MSLC310
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-04-17
false
0000064670
MEDTRONIC INC
MDT
0001438538
Szyman Catherine M
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS
MN
55432
false
true
false
false
SrVP & Pres Diabetes
Common Stock
2014-04-17
4
M
false
6960
35.92
A
28562.299
D
Common Stock
2014-04-17
4
M
false
9241
48.7
A
37803.299
D
Common Stock
2014-04-17
4
M
false
13219
56.74
A
51022.299
D
Common Stock
2014-04-17
4
S
false
29420
58.7872
D
21602.299
D
Employee Stock Option (right to buy)
35.92
2014-04-17
4
M
false
6960
0
D
2010-08-03
2019-08-03
Common Stock
6960
0
D
Employee Stock Option (right to buy)
48.7
2014-04-17
4
M
false
9241
0
D
2007-10-30
2016-10-30
Common Stock
9241
0
D
Employee Stock Option (right to buy)
56.74
2014-04-17
4
M
false
13219
0
D
2006-10-19
2015-10-19
Common Stock
13219
0
D
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
This balance increased by 60 shares due to exempt transactions such as dividend reinvestment or Employee Stock Purchase Plan.
The exercises and sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.36 to $59.17, inclusive. The reporting person undertakes to provide to Medtronic, Inc., any security holder of Medtronic, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4.
Rhonda L. Ingalsbe, Attorney-in-fact
2014-04-21